Robert A. Nathan

9.4k total citations · 3 hit papers
115 papers, 7.2k citations indexed

About

Robert A. Nathan is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Robert A. Nathan has authored 115 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Physiology, 70 papers in Pulmonary and Respiratory Medicine and 44 papers in Immunology and Allergy. Recurrent topics in Robert A. Nathan's work include Asthma and respiratory diseases (92 papers), Respiratory and Cough-Related Research (63 papers) and Allergic Rhinitis and Sensitization (44 papers). Robert A. Nathan is often cited by papers focused on Asthma and respiratory diseases (92 papers), Respiratory and Cough-Related Research (63 papers) and Allergic Rhinitis and Sensitization (44 papers). Robert A. Nathan collaborates with scholars based in United States, United Kingdom and Canada. Robert A. Nathan's co-authors include Mark Kosinski, John Murray, Philip Marcus, Trudy Pendergraft, Christine A. Sorkness, James T. Li, Michael Schätz, Eli O. Meltzer, Priti Jhingran and Michael Schatz and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Robert A. Nathan

109 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of the asthma control test

2004 2.2k citations Robert A. Nathan, Christine A. Sorkness et al. Journal of Allergy and Clinical Immunology profile →
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists

2006 933 citations Christine A. Sorkness, James T. Li et al. Journal of Allergy and Clinical Immunology profile →
Clinical practice guideline: Adult sinusitis

2007 719 citations Robert A. Nathan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Nathan United States	34	5.4k	3.8k	2.3k	1.0k	803	115	7.2k
Françoise Neukirch France	38	4.3k 0.8×	2.8k 0.7×	2.7k 1.2×	273 0.3×	339 0.4×	116	6.2k
Bénédicte Leynaert France	48	5.2k 1.0×	3.3k 0.9×	2.9k 1.3×	174 0.2×	402 0.5×	136	8.3k
Michael S. Blaiss United States	37	3.0k 0.6×	1.2k 0.3×	2.8k 1.2×	316 0.3×	345 0.4×	174	4.5k
James T. Li United States	26	4.0k 0.7×	2.6k 0.7×	2.2k 1.0×	128 0.1×	380 0.5×	66	6.0k
Gary S. Rachelefsky United States	35	1.9k 0.3×	1.5k 0.4×	804 0.3×	578 0.6×	677 0.8×	129	3.8k
Penelope J. Ferrie Canada	17	5.8k 1.1×	3.9k 1.0×	1.5k 0.7×	64 0.1×	326 0.4×	19	7.7k
Anne L. Wright United States	57	9.1k 1.7×	8.1k 2.1×	2.0k 0.9×	220 0.2×	1.0k 1.3×	134	15.6k
Andrew H. Liu United States	49	6.6k 1.2×	3.8k 1.0×	4.2k 1.8×	144 0.1×	1.3k 1.6×	135	10.4k
Catharine J. Holberg United States	43	8.9k 1.6×	8.4k 2.2×	1.7k 0.8×	168 0.2×	978 1.2×	77	14.5k
Cheryl M. Salome Australia	43	4.7k 0.9×	4.2k 1.1×	987 0.4×	62 0.1×	374 0.5×	93	6.3k

Countries citing papers authored by Robert A. Nathan

Since Specialization

Citations

This map shows the geographic impact of Robert A. Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Nathan more than expected).

Fields of papers citing papers by Robert A. Nathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Nathan. The network helps show where Robert A. Nathan may publish in the future.

Co-authorship network of co-authors of Robert A. Nathan

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Nathan. A scholar is included among the top collaborators of Robert A. Nathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Nathan. Robert A. Nathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oppenheimer, John, Huib A.M. Kerstjens, Louis‐Philippe Boulet, et al.. (2024). Characterization of Moderate and Severe Asthma Exacerbations in the CAPTAIN Study. The Journal of Allergy and Clinical Immunology In Practice. 12(9). 2372–2380.e5. 1 indexed citations

Nathan, Robert A., Louis‐Philippe Boulet, Huib A.M. Kerstjens, et al.. (2020). CAPTAIN STUDY: EFFECT OF BASELINE LUNG FUNCTION ON RESPONSE TO TRIPLE THERAPY IN PATIENTS WITH ASTHMA INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID/LONG-ACTING BETA2-AGONIST THERAPY. CHEST Journal. 158(4). A2621–A2625.

Lee, Laurie A., Zelie Bailes, Neil Barnes, et al.. (2020). Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. The Lancet Respiratory Medicine. 9(1). 69–84. 150 indexed citations

Zhang, Xiaoli, Tulin Shekar, Davis Gates, et al.. (2020). Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy. The Journal of Allergy and Clinical Immunology In Practice. 8(5). 1634–1644.e1. 1 indexed citations

Kerwin, Edward, Steven Pascoe, Zelie Bailes, et al.. (2020). A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids. Respiratory Research. 21(1). 148–148. 10 indexed citations

Shekar, Tulin, et al.. (2018). Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate. Journal of Allergy and Clinical Immunology. 143(4). 1395–1402. 17 indexed citations

Gold, Laura S., Kai Yeung, Nancy Smith, et al.. (2013). Asthma control, cost and race: results from a national survey. Journal of Asthma. 50(7). 783–790. 22 indexed citations

Colice, Gene, Nancy K. Ostrom, David E. Geller, et al.. (2012). The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States. Annals of Allergy Asthma & Immunology. 108(3). 157–162.e1. 35 indexed citations

Nathan, Robert A., et al.. (2012). Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial. BMC Pulmonary Medicine. 12(1). 67–67. 30 indexed citations

10.

Nathan, Robert A., et al.. (2010). Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 μg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids. Allergy and Asthma Proceedings. 31(4). 269–279. 32 indexed citations

11.

Nathan, Robert A.. (2010). Intranasal Steroids in the Treatment of Allergy-Induced Rhinorrhea. Clinical Reviews in Allergy & Immunology. 41(1). 89–101. 9 indexed citations

12.

Geller, David E., Michael S. Blaiss, Bob Lanier, et al.. (2009). THE COMPREHENSIVE SURVEY OF HEALTHCARE PROFESSIONALS AND ASTHMA PATIENTS OFFERING INSIGHT ON CURRENT TREATMENT GAPS AND EMERGING DEVICE OPTIONS (C.H.O.I.C.E.): SUBOPTIMAL INHALER TECHNIQUE. CHEST Journal. 136(4). 5S–5S. 1 indexed citations

13.

Nathan, Robert A.. (2009). Management of Patients with Allergic Rhinitis and Asthma: Literature Review. Southern Medical Journal. 102(9). 935–941. 19 indexed citations

14.

Nathan, Robert A., Steven W. Yancey, Barbara A. Prillaman, et al.. (2005). Fluticasone Propionate Nasal Spray Is Superior to Montelukast for Allergic Rhinitis While Neither Affects Overall Asthma Control. CHEST Journal. 128(4). 1910–1920. 32 indexed citations

15.

Weiler, John M., Robert A. Nathan, Ned T. Rupp, et al.. (2005). Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. Annals of Allergy Asthma & Immunology. 94(1). 65–72. 45 indexed citations

16.

Nathan, Robert A., Christine A. Sorkness, Mark Kosinski, et al.. (2004). Development of the asthma control test. Journal of Allergy and Clinical Immunology. 113(1). 59–65. 2184 indexed citations breakdown →

17.

Nathan, Robert A., et al.. (2002). Effect of fluticasone propionate/salmeterol combination product on activity induced bronchospasm in patients with persistent asthma. Journal of Allergy and Clinical Immunology. 109(1). S236–S236. 4 indexed citations

18.

Calhoun, William J., Harold S. Nelson, Robert A. Nathan, et al.. (2001). Comparison of Fluticasone Propionate–Salmeterol Combination Therapy and Montelukast in Patients Who Are Symptomatic on Short-acting β2-Agonists Alone. American Journal of Respiratory and Critical Care Medicine. 164(5). 759–763. 54 indexed citations

19.

Storms, William W., et al.. (1994). Nocturnal Asthma Symptoms May Be More Prevalent than We Think. Journal of Asthma. 31(4). 313–318. 41 indexed citations

20.

Orgel, H.Alice, Eli O. Meltzer, C. Warren Bierman, et al.. (1991). Intranasal fluocortin butyl in patients with perennial rhinitis: A 12-month efficacy and safety study including nasal biopsy. Journal of Allergy and Clinical Immunology. 88(2). 257–264. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact